Recent News

• 12.03.2025 - Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
• 11.21.2025 - Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
• 11.12.2025 - Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
• 11.04.2025 - Supernus Announces Third Quarter 2025 Financial Results
• 10.21.2025 - Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025

Recent Filings

• 11.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.17.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 11.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.04.2025 - 8-K Current report
• 11.04.2025 - EX-99.1 EX-99.1
• 10.21.2025 - EX-99.1 EX-99.1
• 10.21.2025 - 8-K Current report
• 10.16.2025 - 8-K/A Current report
• 10.10.2025 - 4 Statement of changes in beneficial ownership of securities